Inactive Instrument

Insiders Tetraphase Pharmaceuticals, Inc.

Equities

US88165N2045

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Tetraphase Pharmaceuticals, Inc. Announces Executive Changes	20-07-29	CI
Tetraphase Pharmaceuticals, Inc. Announces Resignation of Larry Edwards as CEO	20-07-29	CI
Tetraphase Pharmaceuticals, Inc. Announces Appointment of Michael Hearne as Chief Financial Officer	20-07-29	CI
Tetraphase Pharmaceuticals, Inc. Announces Director Appointments	20-01-23	CI
Tetraphase Pharmaceuticals, Inc. Announces Executive Changes	19-08-08	CI
Tetraphase Pharmaceuticals, Inc. Announces Management Appointments	19-06-12	CI
Tetraphase Pharmaceuticals Promotes Larry Edwards Larry Edwards, Chief Commercial Officer, to Chief Operating Officer	18-03-01	CI
Tetraphase Pharmaceuticals, Inc. Announces Resignation of Kamalam Unninayar as Chief Financial Officer, Effective March 16, 2018	18-02-26	CI
Tetraphase Pharmaceuticals Appoints Larry Tsai, M.D. to Chief Medical Officer	18-01-01	CI
Tetraphase Pharmaceuticals, Inc. Announces Board Changes	17-12-04	CI
Tetraphase Pharmaceuticals, Inc. Appoints Kamalam Unninayar as Chief Financial Officer	17-10-16	CI
Tetraphase Pharmaceuticals, Inc. Elects John Freund as Class III Director	16-06-14	CI
Tetraphase Pharmaceuticals, Inc. Announces Management Changes	16-01-11	CI
Tetraphase Pharmaceuticals, Inc. Announces Resignation of David Lubner as Senior Vice President, Chief Financial Officer, Effective January 8, 2016	16-01-04	CI
Tetraphase Pharmaceuticals, Inc. Announces Resignation of J. Craig Thompson as Chief Operating Officer, Effective from December 31, 2015	15-12-21	CI
Tetraphase Pharmaceuticals Appoints Jacques Dumas as Chief Scientific Officer	15-07-15	CI
Tetraphase Pharmaceuticals, Inc. Announces Board Changes	15-04-15	CI
Tetraphase Pharmaceuticals, Inc. Appoints Maria Stahl as Senior Vice President and General Counsel	15-03-05	CI
Tetraphase Pharmaceuticals, Inc. Approves Election of Class I Directors	14-06-18	CI
Tetraphase Pharmaceuticals Appoints Jeffrey Chodakewitz to the Board of Directors	14-06-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Tetraphase Pharmaceuticals, Inc.

Equities

US88165N2045

Insiders

Filters